Data Services
Compound structure information and bioactivity data services supporting drug discovery, cheminformatics, molecular modeling, and AI-based research.
Data Overview
KCB has accumulated bioactivity test result data from compounds provided to domestic researchers for drug discovery and bio-research since its establishment in 2000.
Approximately 9 million bioactivity data records covering more than 1,450 disease-related targets can support AI-based drug discovery, cheminformatics, molecular modeling, and chemical genomics research.
Available Data
Compound Structure Information
Compound structure information is available for selected compound libraries and focused libraries according to applicable access and use conditions.
Bioactivity Results
Bioactivity test result information disclosed by information providers can be provided for research use.
Focused Libraries
Data may include representative, clinical, natural product, fragment, kinase, PPI, GPCR, and other focused library categories.
Data Scale
Bioactivity Records
9 million
Bioactivity assay data records accumulated through KCB-supported research.
Disease-Related Targets
1,450+
Disease-related targets represented in accumulated bioactivity data.
Disclosed Data
1.6 million
Bioactivity result records available with disclosure consent.
Data Use
Data services support compound evaluation, research planning, cheminformatics analysis, molecular modeling, chemical genomics, and AI-based drug discovery research.
Specific data provision may require an application, review, and data use agreement.
Acknowledgement
Researchers using KCB compounds, data, or services are requested to acknowledge Korea Chemical Bank in publications, presentations, and reports according to KCB guidelines.